Your browser doesn't support javascript.
loading
Integrating biophysics with HTS-driven drug discovery projects.
Folmer, Rutger H A.
Afiliação
  • Folmer RH; Dept of Structure & Biophysics, Discovery Sciences, AstraZeneca R&D, Mölndal SE-431 83, Sweden. Electronic address: rutger.folmer@astrazeneca.com.
Drug Discov Today ; 21(3): 491-8, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26826422
ABSTRACT
Over the past decade biophysics has become an established discipline in HTS hit triaging, owing to its high fidelity in detecting protein-ligand interactions. Many pharma companies are using biophysical techniques to filter HTS output for false positives, as will be discussed in this review. Moreover, I will demonstrate how the earlier application of biophysics, already at the HTS assay development stage, is potentially even more impactful. Two key areas here are early mode-of-action studies and ensuring that the HTS assay and subsequent cascade are fit for purpose. Top-level results from 20 in-house projects are shown to underpin the impact of these studies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Fenômenos Biofísicos / Ensaios de Triagem em Larga Escala Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Fenômenos Biofísicos / Ensaios de Triagem em Larga Escala Idioma: En Ano de publicação: 2016 Tipo de documento: Article